CHICAGO -- Patients with progressive HER2-positive gastroesophageal (GE) cancer lived significantly longer when they received ...

Meitheal Pharma launches generic paclitaxel formulation in US via exclusive commercial licensing agreement with Hong Kong King-Friend: Chicago Saturday, May 31, 2025, 14:00 Hrs [I ...

Vincent Picozzi, MD, medical oncologist and director of the Pancreaticobiliary Program at Virginia Mason, discusses findings ...

特拉维夫 - 专注于肿瘤学和罕见疾病的生物制药公司BioLineRx Ltd. (NASDAQ:TASE: BLRX)，市值为1400万美元，在芝加哥举行的美国临床肿瘤学会 (ASCO)年会上公布了其CheMo4METPANC二期试验的新数据。根据 InvestingPro ...

The company said that updated results from the pilot phase indicate that four of eleven patients remained disease progression ...

但细胞焦亡释放的促炎细胞因子，如 IL-1β，也可能抑制抗肿瘤免疫反应，形成免疫抑制微环境。 紫杉醇：化疗药物的中流砥柱 紫杉醇（Paclitaxel）源自西部紫杉树皮，是广泛用于治疗多种癌症的化疗药物。它主要通过稳定微管蛋白，促进其聚合并抑制解聚 ...

BioLineRx Ltd’s (NASDAQ:BLRX) poster, which includes new data from the single-arm pilot phase of the investigator-initiated, ...

BioLineRx shares were higher after the company reported favorable data from a pilot phase of a drug study of pancreatic cancer patients. Shares rose 45% to $5.51 Friday and are down about 36% this ...

This study identifies 53BP1 as an interaction partner of GMCL1 (a likely CUL3 substrate receptor). The study seeks to link this finding to regulation of the mitotic surveillance pathway and paclitaxel ...

Aim: The COSTABRAX study evaluated the cost–effectiveness of nanoparticle albumin-bound paclitaxel (nab-paclitaxel) versus polyethylated castor oil-based standard paclitaxel (sb-paclitaxel ...

Medtronic (NYSE: MDT) announced today that it received CE mark for several expanded indications for its Prevail balloon ...